Analysis: China was ready to approve mRNA vaccines months ago. Why is it holding off?

When the highly infectious Delta variant hit China in the summer, some public health experts were hopeful that the country could soon receive an immunity boost from BioNTech’s highly effective mRNA Covid-19 vaccine.
http://dlvr.it/SFGNrX

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top